Welcome to LookChem.com Sign In|Join Free

CAS

  • or

80876-00-2

Post Buying Request

80876-00-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

80876-00-2 Usage

Chemical structure

benzophenone derivative with a bromine atom at the 3-position and an amino group at the 2-position of the benzene ring

Primary use

building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds

Biological activities

studied for potential biological activities

Reactant

used in the production of various organic substances

Hazards

should be handled with caution as it can pose hazards to human health and the environment if not properly managed

Check Digit Verification of cas no

The CAS Registry Mumber 80876-00-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,8,7 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 80876-00:
(7*8)+(6*0)+(5*8)+(4*7)+(3*6)+(2*0)+(1*0)=142
142 % 10 = 2
So 80876-00-2 is a valid CAS Registry Number.

80876-00-2Relevant articles and documents

Continuous Flow Synthesis of ACE Inhibitors From N-Substituted l-Alanine Derivatives

Breen, Christopher P.,Jamison, Timothy F.

supporting information, p. 14527 - 14531 (2019/11/03)

A strategy for the continuous flow synthesis of angiotensin converting enzyme (ACE) inhibitors is described. An optimization effort guided by in situ IR analysis resulted in a general amide coupling approach facilitated by N-carboxyanhydride (NCA) activation that was further characterized by reaction kinetics analysis in batch. The three-step continuous process was demonstrated by synthesizing 8 different ACE inhibitors in up to 88 % yield with throughputs in the range of ≈0.5 g h?1, all while avoiding both isolation of reactive intermediates and process intensive reaction conditions. The process was further developed by preparing enalapril, a World Health Organization (WHO) essential medicine, in an industrially relevant flow platform that scaled throughput to ≈1 g h?1.

Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids

Blankley,Kaltenbronn,DeJohn,Werner,Bennett,Bobowski,Krolls,Johnson,Pearlman,Hoefle

, p. 992 - 998 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 80876-00-2